23 May 2013
Keywords: encore, sees, promise, r-flurbiprofen, pharmaceuticals, start-up, company
Article | 18 April 2000
Encore Pharmaceuticals, a US start-up company, says that its leadcompound, R-flurbiprofen (E-7869), has been shown to be safe in a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2000
20 December 1999
22 May 2013
© 2013 thepharmaletter.com